You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Innovative therapies

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Triple-negative Breast Cancers in Order to Validate Interest of

Not yet recruiting
  • Triple Negative Breast Cancer
  • Organoid
  • Establishment of ex vivo breast cancer organoid models
  • Caen, France
    Centre François Baclesse
Aug 9, 2022

APOLLO 11, Consortium of Italian Centers Involved in Treatment

Not yet recruiting
  • NSCLC
  • +4 more
    • (no location specified)
    Sep 19, 2022

    Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, H3 K27M-Mutant Trial in Villejuif (Everolimus, ONC201, Radiotherapy)

    Not yet recruiting
    • Diffuse Intrinsic Pontine Glioma
    • Diffuse Midline Glioma, H3 K27M-Mutant
    • Villejuif, Val De Marne, France
      Gustave Roussy
    Jul 27, 2022

    Spinal Muscular Atrophy Trial in Paris (Motor function measurement using inertial sensors)

    Not yet recruiting
    • Spinal Muscular Atrophy
    • Motor function measurement using inertial sensors
    • Paris, France
      Hôpital Necker-Enfants Malades
    Jun 26, 2021

    Constitution of ex Vivo Ovarian Tumor Models for Validation of

    Recruiting
    • Ovarian Cancer
    • collection of blood, urine, tumor and ascite samples
    • Caen, France
      Centre François BACLESSE
    Jul 20, 2021

    Neuroblastoma Trial (Topotecan, Temozolomide, Ribociclib)

    Not yet recruiting
    • Neuroblastoma
    • (no location specified)
    Jun 17, 2022

    Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic

    Not yet recruiting
    • Acute Lymphoblastic Leukemia
    • +4 more
    • Utrecht, Netherlands
      Princess Máxima Center for Pediatric Oncology
    Feb 20, 2023

    Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent,

    Not yet recruiting
    • Acute Lymphoblastic Leukemia, in Relapse
    • +4 more
    • Utrecht, Netherlands
      Princess Máxima Center for Pediatric Oncology
    Feb 16, 2023

    Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent,

    Not yet recruiting
    • Acute Lymphoblastic Leukemia, in Relapse
    • +4 more
    • Utrecht, Netherlands
      Princess Máxima Center for Pediatric Oncology
    Feb 22, 2023

    Type 1 Diabetes Trial in New Haven (Follicular Euglycemic clamp, Luteal Euglycemic clamp)

    Completed
    • Type 1 Diabetes
    • Follicular Euglycemic clamp
    • Luteal Euglycemic clamp
    • New Haven, Connecticut
      Yale University School of Medicine
    Feb 9, 2022

    Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent,

    Not yet recruiting
    • Acute Lymphoblastic Leukemia, in Relapse
    • +4 more
    • Utrecht, Netherlands
      Princess Máxima Center for Pediatric Oncology
    Dec 13, 2022

    Neuroblastoma Trial in Worldwide (LY3295668 Erbumine, Topotecan, Cyclophosphamide)

    Active, not recruiting
    • Neuroblastoma
    • LY3295668 Erbumine
    • +2 more
    • San Francisco, California
    • +21 more
    Aug 17, 2022

    Esophageal Squamous Cell Carcinoma (ESCC) Trial in Japan, Taiwan (Pembrolizumab, Coformulation favezelimab/pembrolizumab,

    Recruiting
    • Esophageal Squamous Cell Carcinoma (ESCC)
    • Pembrolizumab
    • +5 more
    • Milan, Lombardia, Italy
    • +13 more
    Jan 3, 2023

    Leukemia Trial in Worldwide (Dasatinib)

    Completed
    Has Results
    • Leukemia
    • Vienna, Austria
    • +12 more
    Feb 24, 2021

    Acute Myeloid Leukemia Trial in Worldwide (Quizartinib, Intrathecal (IT) triple chemo prophylaxis, Fludarabine)

    Recruiting
    • Acute Myeloid Leukemia
    • Loma Linda, California
    • +36 more
    Feb 1, 2023

    Relapsed or Refractory Pediatric Tumor Trial in Worldwide (biopsy or surgical resection of tumor and blood sampling)

    Unknown status
    • Relapsed or Refractory Pediatric Tumor
    • biopsy or surgical resection of tumor and blood sampling
    • Villejuif, Val De Marne, France
    • +4 more
    Feb 14, 2020

    Cancer, Melanoma Trial in Worldwide (drug, biological, other)

    Recruiting
    • Cancer
    • Melanoma
    • Springdale, Arkansas
    • +70 more
    May 16, 2022

    Uterine Cervical Tumors, Endometrial Tumors, Squamous Cell Carcinoma of Head and Neck Trial in Worldwide

    Recruiting
    • Uterine Cervical Neoplasms
    • +10 more
    • Pembrolizumab/Vibostolimab Co-Formulation
    • +11 more
    • Anchorage, Alaska
    • +65 more
    Jan 27, 2023

    Sleep Apnea, SCI/D, Hypercapnia Trial in Detroit (Hypercapnia treatment, Sham treatment)

    Not yet recruiting
    • Sleep Apnea
    • +2 more
    • Hypercapnia treatment
    • Sham treatment
    • Detroit, Michigan
      John D. Dingell VA Medical Center, Detroit, MI
    Sep 9, 2022

    Including miRNA-based Tumor Signatures in Diffuse Large B Cell

    Not yet recruiting
    • Diffuse Large B Cell Lymphoma
    • Relapsed Non-Hodgkin Lymphoma
    • no intervention (observational study)
    • Napoli, Italy
    • +2 more
    Feb 17, 2023

    Healthy (For Part A), Chronic Myeloid Leukemia (for Part B and C) Trial in Worldwide (Vodobatinib (K0706) capsules)

    Recruiting
    • Healthy (For Part A)
    • Chronic Myeloid Leukemia (for Part B and C)
    • Vodobatinib (K0706) capsules
    • Downey, California
    • +69 more
    Dec 7, 2022

    Nonsmall Cell Lung Cancer, NSCLC Trial in Worldwide (NovoTTF-200T, Immune checkpoint inhibitors or docetaxel)

    Active, not recruiting
    • Nonsmall Cell Lung Cancer
    • NSCLC
    • NovoTTF-200T
    • Immune checkpoint inhibitors or docetaxel
    • Birmingham, Alabama
    • +123 more
    Oct 13, 2022

    Therapeutic Monitoring of Infliximab and Adalimumab

    Recruiting
    • Inflammatory Bowel Diseases
    • Trieste, Italy
      IRCCS Burlo Garofolo
    Sep 5, 2023

    Acute Lymphoblastic Leukemia (ALL) Trial in Worldwide (Carfilzomib, Dexamethasone, Mitoxantrone)

    Recruiting
    • Acute Lymphoblastic Leukemia (ALL)
    • Orange, California
    • +86 more
    Nov 14, 2022

    Type 1 Diabetes, Type 2 Diabetes Trial in Boston (Diabetes Collaborative Care Model for Young Adults, Usual Care Model)

    Active, not recruiting
    • Type 1 Diabetes
    • Type 2 Diabetes
    • Diabetes Collaborative Care Model for Young Adults
    • Usual Care Model
    • Boston, Massachusetts
      Massachusetts General Hospital
    Dec 20, 2022